Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News

$Acumen Pharmaceuticals (ABOS.US)$ Acumen Pharmaceuticals, Inc. And Halozyme Enter Global Collaboration And License Agreement To Develop Subcutaneous Formulation Of ACU193 With ENHANZE Technology
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
6506 Views
Comment
Sign in to post a comment
    3443Followers
    27Following
    51KVisitors
    Follow